We all feel tremendously lucky that we could make a decision about our bodies and our health from a place of being healthy. BRCA1/BRCA2 (Selected Variants Genetic Health Risk Report)*


BRCA1/BRCA2 (Selected Variants Genetic Health Risk Report)*

When she was in her early thirties, Ann learned she had been conceived by a sperm donor. She decided to take the 23andMe test when she was asked at a medical exam if she had a family history of breast cancer and realized she didn’t know the answer.

When Ann received her 23andMe results, she learned that she was 51% Ashkenazi Jewish.  After opting into 23andMe’s Genetic Health Risk reports, she also learned she had a BRCA1 mutation. Her doctor ordered a blood test, which confirmed her positive result. She consulted with a gynecologic oncologist to determine a proper course of action.  Ann attended support meetings to learn how to cope.  Looking back, she feels fortunate to have been able to access information that allowed her to be proactive about her health.

Learn More
Sample report: 1 variant, 1 copy (BRCA1) - female
All Available Reports: Click here

See Additional Customer Stories

*The 23andMe PGS test uses qualitative genotyping to detect select clinically relevant variants in the genomic DNA of adults from saliva for the purpose of reporting and interpreting genetic health risks and reporting carrier status. It is not intended to diagnose any disease. Your ethnicity may affect the relevance of each report and how your genetic health risk results are interpreted. Each genetic health risk report describes if a person has variants associated with a higher risk of developing a disease, but does not describe a person’s overall risk of developing the disease. The test is not intended to tell you anything about your current state of health, or to be used to make medical decisions, including whether or not you should take a medication, how much of a medication you should take, or determine any treatment. Our carrier status reports can be used to determine carrier status, but cannot determine if you have two copies of any genetic variant. These carrier reports are not intended to tell you anything about your risk for developing a disease in the future, the health of your fetus, or your newborn child’s risk of developing a particular disease later in life. For certain conditions, we provide a single report that includes information on both carrier status and genetic health risk. Warnings & Limitations: The 23andMe PGS Genetic Health Risk Report for BRCA1/BRCA2 (Selected Variants) is indicated for reporting of the 185delAG and 5382insC variants in the BRCA1 gene and the 6174delT variant in the BRCA2 gene. The report describes if a woman is at increased risk of developing breast and ovarian cancer, and if a man is at increased risk of developing breast cancer or may be at increased risk of developing prostate cancer. The three variants included in this report are most common in people of Ashkenazi Jewish descent and do not represent the majority of BRCA1/BRCA2 variants in the general population. This report does not include variants in other genes linked to hereditary cancers and the absence of variants included in this report does not rule out the presence of other genetic variants that may impact cancer risk. The PGS test is not a substitute for visits to a healthcare professional for recommended screenings or appropriate follow-up. Results should be confirmed in a clinical setting before taking any medical action. For important information and limitations regarding other genetic health risk reports and carrier status reports, visit https://www.23andme.com/test-info/ .